![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
P Seeman, M Watanabe, D Grigoriadis, JL Tedesco, SR George, U Svensson, JL Nilsson and JL Neumeyer
In order to develop a model for the putative binding sites between the D2 dopamine receptor and many of its agonists, we obtained the dissociation constants of many dopaminergic agonists at the high affinity state, D2high, as well as at the low affinity state, D2low, of the receptor. [3H]Spiperone was used to label the D2 dopamine receptors in porcine anterior pituitary tissue. Agonists without any hydroxyl groups, such as 2-aminotetralin, effectively inhibited the binding of [3H]spiperone; the addition of a hydroxyl group corresponding to the "meta" position in dopamine, however, enhanced the potency (in four series of agonists) by an order of magnitude. The R-(-)-enantiomers of the aporphines and 5,6,-dihydroxy-2-dipropylaminotetralin were more potent than the S-(+)-enantiomers. Although the 4-methoxy-2- dipropylaminoindans were potent, the R-(-)-11-methoxyaporphines were not. A tetrahedral model is proposed; this has two sites for agonist attachment, the extremities of the sites being separated by 8 A, and their functional groups directed between 15 degrees and 30 degrees off the orthogonal from the receptor surface. Several steric obstacles are required to account for the inactivity of several congeners.
This article has been cited by other articles:
|
|
 |
|
  T. Gornemann, H. Hubner, P. Gmeiner, R. Horowski, K. P. Latte, M. Flieger, and H. H. Pertz Characterization of the Molecular Fragment That Is Responsible for Agonism of Pergolide at Serotonin 5-Hydroxytryptamine2B and 5-Hydroxytryptamine2A Receptors J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1136 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Narendran, D.-R. Hwang, M. Slifstein, Y. Hwang, Y. Huang, J. Ekelund, O. Guillin, E. Scher, D. Martinez, and M. Laruelle Measurement of the Proportion of D2 Receptors Configured in State of High Affinity for Agonists in Vivo: A Positron Emission Tomography Study Using [11C]N-Propyl-norapomorphine and [11C]Raclopride in Baboons J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 80 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-R. Hwang, R. Narendran, Y. Huang, M. Slifstein, P. S. Talbot, Y. Sudo, B. N. Van Berckel, L. S. Kegeles, D. Martinez, and M. Laruelle Quantitative Analysis of (-)-N-11C-Propyl-Norapomorphine In Vivo Binding in Nonhuman Primates J. Nucl. Med., February 1, 2004; 45(2): 338 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Guiramand, J.-P. Montmayeur, J. Ceraline, M. Bhatia, and E. Borrelli Alternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteins J. Biol. Chem., March 31, 1995; 270(13): 7354 - 7358. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
